Interestingly, Ship2 modulates EGFR (Epidermal Growth Factor Receptor) signaling: down-regulation of Ship2 in breast cancer cell lines improves EGFR internalization and degradation and arrests cell proliferation8. Here, EGFR is linked to breast carcinoma.